Literature DB >> 31613328

Comparison of Microneutralization and Histo-Blood Group Antigen-Blocking Assays for Functional Norovirus Antibody Detection.

Robert L Atmar1,2, Khalil Ettayebi2, B Vijayalakshmi Ayyar2, Frederick H Neill2, Ralph P Braun3, Sasirekha Ramani2, Mary K Estes1,2.   

Abstract

BACKGROUND: The development of an in vitro cultivation system for human noroviruses allows the measurement of neutralizing antibody levels.
METHODS: Serum neutralizing antibody levels were determined using a GII.4/Sydney/2012-like virus in human intestinal enteroids in samples collected before and 4 weeks after administration of an investigational norovirus vaccine and were compared with those measured in histo-blood group antigen (HBGA)-blocking assays.
RESULTS: Neutralizing antibody seroresponses were observed in 71% of 24 vaccinated adults, and antibody levels were highly correlated (r = 0.82, P < .001) with those measured by HBGA blocking.
CONCLUSIONS: HBGA-blocking antibodies are a surrogate for neutralization in human noroviruses. CLINICAL TRIALS REGISTRATION: NCT02475278.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  human norovirus; antibody; histo-blood group antigen; human intestinal enteroids; immunogenicity; neutralization; vaccine

Mesh:

Substances:

Year:  2020        PMID: 31613328     DOI: 10.1093/infdis/jiz526

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

1.  Antigenic Site Immunodominance Redirection Following Repeat Variant Exposure.

Authors:  Lisa C Lindesmith; Paul D Brewer-Jensen; Michael L Mallory; Mark R Zweigart; Samantha R May; Daniel Kelly; Rachel Williams; Sylvia Becker-Dreps; Filemón Bucardo; David J Allen; Judith Breuer; Ralph S Baric
Journal:  Viruses       Date:  2022-06-14       Impact factor: 5.818

Review 2.  Put Some Guts into It: Intestinal Organoid Models to Study Viral Infection.

Authors:  Inés García-Rodríguez; Adithya Sridhar; Dasja Pajkrt; Katja C Wolthers
Journal:  Viruses       Date:  2020-11-11       Impact factor: 5.048

3.  Antigenic cartography reveals complexities of genetic determinants that lead to antigenic differences among pandemic GII.4 noroviruses.

Authors:  Joseph A Kendra; Kentaro Tohma; Lauren A Ford-Siltz; Cara J Lepore; Gabriel I Parra
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-16       Impact factor: 11.205

Review 4.  Understanding the relationship between norovirus diversity and immunity.

Authors:  Lauren A Ford-Siltz; Kentaro Tohma; Gabriel I Parra
Journal:  Gut Microbes       Date:  2021 Jan-Dec

5.  Complete genome characterization of human noroviruses allows comparison of minor alleles during acute and chronic infections.

Authors:  Daniel Kelly; Khuzwayo C Jere; Alistair C Darby; David J Allen; Miren Iturriza-Gómara
Journal:  Access Microbiol       Date:  2021-02-17

6.  Experimental Methods to Study the Pathogenesis of Human Enteric RNA Viruses.

Authors:  Somya Aggarwal; Ebrahim Hassan; Megan T Baldridge
Journal:  Viruses       Date:  2021-05-25       Impact factor: 5.048

7.  Virus-Host Interactions Between Nonsecretors and Human Norovirus.

Authors:  Lisa C Lindesmith; Paul D Brewer-Jensen; Michael L Mallory; Kara Jensen; Boyd L Yount; Veronica Costantini; Matthew H Collins; Caitlin E Edwards; Timothy P Sheahan; Jan Vinjé; Ralph S Baric
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2020-04-11

8.  Genetic Manipulation of Human Intestinal Enteroids Demonstrates the Necessity of a Functional Fucosyltransferase 2 Gene for Secretor-Dependent Human Norovirus Infection.

Authors:  Kei Haga; Khalil Ettayebi; Victoria R Tenge; Umesh C Karandikar; Miranda A Lewis; Shih-Ching Lin; Frederick H Neill; B Vijayalakshmi Ayyar; Xi-Lei Zeng; Göran Larson; Sasirekha Ramani; Robert L Atmar; Mary K Estes
Journal:  mBio       Date:  2020-03-17       Impact factor: 7.867

9.  Broadly cross-reactive human antibodies that inhibit genogroup I and II noroviruses.

Authors:  Gabriela Alvarado; Wilhelm Salmen; Khalil Ettayebi; Liya Hu; Banumathi Sankaran; Mary K Estes; B V Venkataram Prasad; James E Crowe
Journal:  Nat Commun       Date:  2021-07-14       Impact factor: 14.919

Review 10.  Norovirus in Cancer Patients: A Review.

Authors:  Divya Samantha Kondapi; Sasirekha Ramani; Mary K Estes; Robert L Atmar; Pablo C Okhuysen
Journal:  Open Forum Infect Dis       Date:  2021-03-14       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.